durvalumab 120 in 2.4 ML Injection

RxCUI: 1919507
RxNorm name: durvalumab 120 in 2.4 ML Injection
Display name: durvalumab 120 in 2.4 ML Injection
Full name: durvalumab 120 in 2.4 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761069	Imfinzi	durvalumab	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
IMFINZI	DURVALUMAB	AstraZeneca Pharmaceuticals LP	8baba4ea-2855-42fa-9bd9-5a7548d4cec3	2026-05-28	Warnings, Adverse reactions	Exact identifier rxcui: 1919507

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
8baba4ea-2855-42fa-9bd9-5a7548d4cec3	durvalumab 120 in 2.4 ML Injection [PSN] · 2.4 ML durvalumab 50 MG/ML Injection [SCD] · durvalumab 120 per 2.4 ML Injection [SY]	3	32	These highlights do not include all the information needed to use IMFINZI safely and effectively. See full prescribing information for IMFINZI. IMFINZI ® (durvalumab) injection, for intravenous use Initial U.S. Approval: 2017	20251125